The industrial food additive, microbial transglutaminase, mimics tissue transglutaminase and is immunogenic in celiac disease patients

Autoimmunity Reviews

Volumn 15, Issue 12, 2016, Pages 1111-1119

  Matthias, T ^a   Jeremias, P ^a   Neidhofer S ^a   Lerner, A ^a,b  

^a Mikroforum Ring   (Germany)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antibodies; Celiac disease; Food additive; Food processing; Immunogenic; Immunoreactivity; Microbial transglutaminase; Tissue transglutaminase

Indexed keywords

FOOD ADDITIVE; GLIADIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

CELIAC DISEASE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIELD FLOW FRACTIONATION; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; INTESTINE INJURY; MAJOR CLINICAL STUDY; OPTICAL DENSITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVIEW; SEROLOGY; CHEMISTRY; FOOD HANDLING; IMMUNOLOGY;

CELIAC DISEASE; FOOD ADDITIVES; FOOD HANDLING; HUMANS; TRANSGLUTAMINASES;

EID: 84994523257     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.09.011     Document Type: Review

References (51)

1. [1] Lerner, A., Jermias, P., Matthias, T., The world incidence of celiac disease is increasing: a review. Int Recent Sci Res 7 (2015), 5491–5496.
2. [2] Lerner, A., Jeremias, P., Matthias, T., The world incidence and prevalence of autoimmune diseases is increasing: a review. Int J Celiac Dis 3 (2015), 151–155.
3. [3] Lerner, A., Matthias, T., Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis. Nutr Rev 73 (2015), 544–552.
4. [4] Lerner, A., Matthias, T., Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev 14 (2015), 479–489.
5. [5] Kieliszek, M., Misiewicz, A., Microbial transglutaminase and its application in the food industry. A review. Folia Microbiol 59 (2014), 241–250.
6. [6] Strop, P., Versatility of microbial transglutaminase. Bioconjug Chem 25 (2014), 855–862.
7. [7] Reef, S., Lerner, A., Tissue transglutaminase—the key player in celiac disease—a review. Autoimmun Rev 3 (2004), 40–45.
8. [8] Lerner, A., Neidhöfer, S., Matthias, T., Transglutaminase 2 and anti transglutaminase 2 autoantibodies in celiac disease and beyond: Part A: TG2 double-edged sword: gut and extraintestinal involvement. Immunol Res 11 (2015), 101–105.
9. [9] Lerner, A., Neidhöfer, S., Matthias, T., Transglutaminase 2 and anti transglutaminase 2 autoantibodies in celiac disease and beyond. Part B: anti-transglutaminase 2 autoantibodies: friends or enemies. Immunol Res 11 (2015), 3–7.
10. [10] Lerner, A., Jeremias, P., Matthias, T., Outside of normal limits: false +/− anti TG2 autoantibodies. Int J Celiac Dis 3 (2015), 87–90.
11. [11] Lerner, A., Matthias, T., Food industrial microbial transglutaminase in celiac disease: treat or trick. Int J Celiac Dis 3 (2015), 1–6.
12. [12] Hall, E.H., Crowe, S.E., Environmental and lifestyle influences on disorders of the large and small intestine: Implication for treatment. Dig Dis 29 (2011), 249–254.
13. [13] Lerner, A., Factors affecting the clinical presentation and time diagnosis of celiac disease: the Jerusalem and the West Bank–Gaza experience. Isr J Med Sci 11 (1994), 294–295.
14. [14] Lerner, A., Agmon-Levin, N., Shapira, Y., Gilburd, B., Reuter, S., Lavi, I., Shoenfeld, Y., The thrombophilic network of autoantibodies in celiac disease. BMC Med, 11, 2013, 89.
15. [15] Lerner, A., Reif, S., Nonnutritional environmental factors associated with Celiac disease: The Infectome. Shoenfeld, Y, Agmon-Levine, N, Rose, NR, (eds.) Infections and Autoimmunity, 2nd Ed., 2015, Elsevier B.V. Chapter 50, 829–837.
16. [16] Lebwohl, B., Ludvigsson, J.F., Green, P.H.R., The unfolding story of celiac disease risk factors. Clin Gastroenterol Hepatol 12 (2014), 632–635.
17. [17] Gaspar, A.L., de Góes-Favoni, S.P., Action of microbial transglutaminase (MTGase) in the modification of food proteins: a review. Food Chem 171 (2015), 315–322.
18. [18] Rozenberg, O., Lerner, A., Pacht, A., Grinberg, M., Reginashvili, D., Henig, C., Barak, M., A new algorithm for the diagnosis of celiac disease. Cell Mol Immunol 8 (2011), 146–149.
19. [19] Walker-Smith, J.A., Guandalini, S., Schmitz, J., et al. Revised criteria for the diagnosis of celiac disease. Report of the working group of European Society of Pediatric Gastroenterology and Nutrition. Arch Dis Child, 65, 1990, 909911.
20. [20] Konagurthu, A.S., Whisstock, J.C., Stuckey, P.J., Lesk, A.M., MUSTANG: a multiple structural alignment algorithm. Proteins 64 (2006), 559–574.
21. [21] Krieger, E., Increasing the precision of comparative models with YASARA NOVA. A self parameterizing force field. Proteins, 47, 2002, 393–402 [S.].
22. [22] Berti, C., Roncoroni, L., Falini, M.L., et al. Celiac-related properties of chemically and enzymatically modified gluten proteins. J Agric Food Chem 55 (2007), 2482–2488.
23. [23] Cabrera-Chavez, F., Rouzaud-Sandez, O., Sotelo-Cruz, N., Calderon De La Barca, A.M., Bovine milk caseins and transglutaminase-treated cereal prolamins are differentially recognized by IgA of celiac disease patients according to age. J Agric Food Chem 57 (2009), 3754–3759.
24. [24] Cabrera-Chavez, F., Rouzaud-Sandez, O., Sotelo-Cruz, N., Calderon De La Barca, A.M., Transglutaminase treatment of wheat and maize prolamins of bread increase the serum IgA reactivity of celiac disease patients. Agaric Food Chem 56 (2008), 1387–1391.
25. [25] Rozenberg, O., Lerner, A., Pacht, A., Grinberg, M., Reginashvili, D., Henig, C., Barak, M., A novel algorithm for the diagnosis of celiac disease and a comprehensive review of celiac disease diagnostics. Clin Rev Allergy Immunol 42 (2012), 331–341.
26. [26] Tucker, N.T., Barghuthy, F.S., Prihoda, T.J., Kumar, V., Lerner, A., Lebenthal, E., Antigliadin antibodies detected by enzyme linked immunosorbent assay (ELISA) as a marker of childhood celiac disease. J Pediatr 113 (1988), 286–289.
27. [27] Kumar, V., Lerner, A., Valeski, J.E., Beutner, E.H., Chorzelski, T.P., Rossi, T.M., Endomysial antibodies in the diagnosis of celiac disease and the effect of gluten on antibody titers. Immunol Invest 18 (1989), 533–544.
28. [28] Shaoul, R., Lerner, A., Associated authoantibodies in celiac disease. Autoimmun Rev 6 (2007), 559–565.
29. [29] Lerner, A., Jeremias, P., Neidhöfer, S., Matthias, T., Antibodies against neo-epitope tTg complexed to gliadin are different and more reliable then anti-tTg for the diagnosis of pediatric celiac disease. J Immunol Methods 429 (2016), 15–20.
30. [30] Falini, M.L., Elli, L., Caramanico, R., Bardella, M.T., Terrani, C., Roncoroni, L., Doneda, L., Forlani, F., Immunoreactivity of antibodies against transglutaminase-deamidated gliadins in adult celiac disease. Dig Dis Sci 53 (2008), 2697–2701.
31. [31] Heredia-Sandoval, N.G., Islas-Rubio, A.R., Cabrera-Chávez, F., Calderón de la Barca, A.M., Transamidation of gluten proteins during the bread-making process of wheat flour to produce breads with less immunoreactive gluten. Food Funct 5 (2014), 1813–1818.
32. [32] Ruh, T., Ohsam, J., Pasternack, R., Yokoyama, K., Kumazawa, Y., Hils, M., Microbial transglutaminase treatment in pasta-production does not affect the immunoreactivity of gliadin with celiac disease patients’ sera. J Agric Food Chem 62 (2014), 7604–7611.
33. [33] Dekking, E.H.A., Van Veelen, P.A., de Ru, A., et al. Microbial transglutaminase generate T cell stimulatory epitopes involved in celiac disease. J Cereal Sci 47 (2008), 339–346.
34. [34] Elli, L., Roncoroni, L., Hils, M., Pasternack, R., Barisani, D., Terrani, C., Vaira, V., Ferrero, S., Bardella, M.T., Immunological effects of transglutaminase-treated gluten in coeliac disease. Hum Immunol 73 (2012), 992–997.
35. [35] Tian, N., Wei, G., Schuppan, D., Helmerhorst, E.J., Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation and immunogenic epitopes relevant to celiac disease. Am J Physiol Gastrointest Liver Physiol, 21, Aug 2014 [Epub ahead of print].
36. [36] Caja, S., Mäki, M., Kaukinen, K., Lindfors, K., Antibodies in celiac disease: implications beyond diagnostics. Cell Mol Immunol 8 (2011), 103–109.
37. [37] de Sousa Moraes, L.F., Grzeskowiak, L.M., de Sales Teixeira, T.F., Gouveia Peluzio Mdo, C., Intestinal microbiota and probiotics in celiac disease. Clin Microbiol Rev 27 (2014), 482–489.
38. [38] Viitasalo, L., Niemi, L., Ashorn, M., Ashorn, S., Braun, J., Huhtala, H., et al. Early microbial markers of celiac disease. J Clin Gastroenterol 48 (2014), 620–624.
39. [39] Fasano, A., Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev 91 (2011), 151–175.
40. [40] Uhlig, H.H., Lichtenfeld, J., Osman, A.A., Richter, T., Mothes, T., Evidence for existence of coeliac disease autoantigens apart from tissue transglutaminase. Eur J Gastroenterol Hepatol 12 (2000), 1017–1020.
41. [41] Stulík, J., Hernychová, L., Porkertová, S., Pozler, O., Tucková, L., Sánchez, D., Bures, J., Identification of new celiac disease autoantigens using proteomic analysis. Proteomics 3 (2003), 951–956.
42. [42] Dalleywater, W.J., Chau, D.Y.S., Ghaemmaghami, A.M., Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype - implications for the role of transglutaminase in coeliac disease. BMC Immunol, 13, 2012, 20.
43. [43] Kalliokoski, S., Caja, S., Frias, R., Laurila, K., et al. Injection of celiac disease patient sera or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease. J Mol Med (Berl) 93 (2015), 51–62.
44. [44] Vojdani, A., Detection of IgE, IgG, IgA and IgM antibodies against raw and processed food antigens. Nutr Metab (Lond), 6, 2009, 22.
45. [45] www.transglutaminase.com/celiac-disease-amp-tg/can-people-with-celiac-eat.
46. [46] www.bag.admin.ch. Art 9.
47. [47] Rossi, T.M., Kumar, V., Lerner, A., Heitlinger, L.A., Tucker, N., Fisher, J., Relationship of endomysial antibodies to jejunal mucosa pathology: specificity towards both symptomatic and asymptomatic celiacs. J Pediatr Gastroenterol Nutr 7 (1988), 858–863.
48. [48] Lerner, A., Neidhöfer, S., Matthias, T., Serological markers and/or intestinal biopsies in the case-finding of celiac disease. Editorial. Int J Celiac Dis 3 (2015), 53–55.
49. [49] Lerner, A., Kumar, V., Iancu, T.C., Immunological diagnosis of childhood celiac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exper Immunol 95 (1994), 78–82.
50. [50] Lerner, A., Serological diagnosis of celiac disease—moving beyond the tip of the iceberg. Int J Celiac Dis 2 (2014), 64–66 [Editorial].
51. [51] Dieterich, W., Laag, E., Schöpper, H., Volta, U., Ferguson, A., Gillett, H., Riecken, E.O., Schuppan, D., Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115:6 (Dec 1998), 1317–1321.